Indeed, male germ-line-selective advantage has previously been described for mutations in other genes involved in cancer (e.g. FGFR2, FGFR3, RET, PTPN11) that cause congenital disorders with paternal age effect69–77. The gene discussed is FGFR2; the disease is cancer.